Tricuspid Stenosis Medication

Updated: Sep 25, 2016
  • Author: Mary C Mancini, MD, PhD, MMM; Chief Editor: Richard A Lange, MD, MBA  more...
  • Print
Medication

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Next:

Antiarrhythmic agents

Class Summary

Alter the electrophysiologic mechanisms responsible for arrhythmia.

Digoxin (Lanoxin)

Cardiac glycoside with direct inotropic effects and indirect effects on the cardiovascular system. Acts directly on cardiac muscle and increases myocardial systolic contractions. Indirect actions result in increased carotid sinus nerve activity and enhanced sympathetic withdrawal for any given increase in mean arterial pressure.

Previous
Next:

Anticoagulants

Class Summary

Used for prophylaxis and treatment of venous thrombosis, pulmonary embolism, and thromboembolic disorders.

Warfarin (Coumadin)

Interferes with hepatic synthesis of vitamin K–dependent coagulation factors. Tailor dose to maintain an INR in the range of 2-3.

Previous